Pharmalot Ed Silverman STAT Plus: Sanofi becomes the third leading insulin maker to lower list prices, cutting Lantus price by 78%
Politics Rachel Cohrs STAT Plus: The big-money Medicare policy that has hospitals worried this Congress
Politics Rachel Cohrs STAT Plus: Biden administration to fine manufacturers of 27 medicines for price hikes
First Opinion Daniel Fass and David Townsend NRC: be straight about when clinicians need to report errors that lead to radiation exposure
Politics Joanne Silberner STAT Plus: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
Politics Sarah Owermohle STAT Plus: Biden makes big demands for cancer research and new ARPA-H agency
Politics Helen Branswell, Rachel Cohrs and Damian Garde STAT Plus: 8 burning questions Bernie Sanders and other senators should ask Moderna’s Stéphane Bancel
Pharmalot Ed Silverman STAT Plus: Senator calls for probe of conflict of interest on federal panel overseeing dietary guidelines
Biotech Bob Herman and Damian Garde STAT Plus: Moderna CEO made $398 million in 2022, but still pledges to give most to charity
Politics Rachel Cohrs STAT Plus: Biden administration requests $20 billion cash infusion to bolster public health
Politics John Wilkerson STAT Plus: Biden makes drug pricing a central part of his deficit reduction plans
Pharmalot Ed Silverman STAT Plus: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment
Politics Nicholas Florko STAT Plus: With an $11 billion price tag, the White House pitches a plan to end hepatitis C
Politics Rachel Cohrs STAT Plus: Pfizer CEO Albert Bourla maxed out campaign contributions to Dr. Oz ahead of midterm elections
Politics John Wilkerson STAT Plus: Medicare chief on the new drug price negotiation program’s operations, hiring, and timelines
Politics Sarah Owermohle STAT Plus: HHS has an environmental justice office. What’s it doing after East Palestine derailment?
Politics John Wilkerson STAT Plus: By cutting insulin prices, Eli Lilly avoids paying big Medicaid rebates
Politics Avani Kalra — Medill News Service STAT Plus: How policymakers could tweak HIPAA to better protect abortion records
Hospitals John Wilkerson STAT Plus: Government antitrust officials consider letting physician-owned hospitals expand
Pharmalot Ed Silverman STAT Plus: Lawmakers urge U.S. patent office to scrutinize Merck over ‘abuse’ of the system
Politics John Wilkerson STAT Plus: Republicans are using the FTC’s Lina Khan as an excuse for opposing drug pricing bills
Politics Sarah Owermohle STAT Plus: Key Senate committee takes first step toward tackling health workforce shortages
Politics Nicholas Florko STAT Plus: Can food be medicine? Will insurers cover it? And other big questions about a new health movement
Politics Sarah Owermohle STAT Plus: Doctors’ top lobbyist in Washington on Medicare money, burnout, and private equity
Politics Rachel Cohrs STAT Plus: Sen. Tammy Baldwin criticizes Ascension’s for-profit investment activities, requests returns and fees info
Hospitals Bob Herman Patients still have no protection against surprise ambulance bills. And there’s no solution in sight